Brain Tumors Unit
What does the Unit treat?
The Brain Tumors Unit of HM CIOCC is a national reference, specialized in the treatment of glioblastoma multiforme, an aggressive and fast-growing type of brain tumor that originates in glial cells, the brain’s support cells.
At HM Hospitals (CIOCC), the Brain Tumors Unit focuses on:
- Utilization of TTFields, an innovative treatment that uses low-intensity electric fields to disrupt tumor cell division, thereby slowing tumor growth, especially in cases of relapse.
- Development of innovative clinical trials with targeted treatments for patients with glioblastoma multiforme.
- Innovation in blood-brain barrier opening devices for better drug penetration.
Related Diseases
- Glioblastoma.
- Brain Tumors.
Who is this Unit for?
The Brain Tumors Unit is aimed at:
- Patients with glioblastoma multiforme.
- Patients seeking to participate in innovative clinical trials with targeted treatments.
- Patients interested in innovation in blood-brain barrier opening devices.
- Patients seeking treatment for relapses with TTFields.
- Family members and caregivers seeking information and support for their loved ones with brain tumors.
- Healthcare professionals who wish to refer patients for specialized brain tumor evaluation and treatment.
How do we approach it at HM Hospitals?
Surgery
We aim to remove as much of the tumor as possible, preserving the function of the reproductive organs to the maximum extent.
Chemotherapy
We use state-of-the-art medications to reach and destroy cancer cells that may be present anywhere in the body.
Radiotherapy
We direct high-energy beams to destroy cancer cells, minimizing damage to surrounding healthy tissues.
Targeted therapies
They act on specific molecular targets of cancer cells, selectively disrupting their growth and spread.
Immunotherapy
Through drugs, we stimulate the patient’s immune system to naturally recognize and attack cancer cells.
TTFields
We use low-intensity electric fields to interfere with tumor cell division, slowing their growth.